Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$654M |
| 2 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$241M |
| 3 |
iShares Gold Trust
IAU
|
+$232M |
| 4 |
VanEck Oil Services ETF
OIH
|
+$200M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$165M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$852M |
| 2 |
Microsoft
MSFT
|
+$575M |
| 3 |
Carvana
CVNA
|
+$540M |
| 4 |
Target
TGT
|
+$430M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.49% |
| 2 | Financials | 5.96% |
| 3 | Consumer Discretionary | 5.3% |
| 4 | Healthcare | 4.99% |
| 5 | Communication Services | 3.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HAYN
3526
DELISTED
Haynes International, Inc.
HAYN
| $443K | ﹤0.01% |
10,391
+865
| +9% | +$34.1K |
|
|
RDUS
3527
CALL
DELISTED
Radius Health, Inc.
RDUS
| $442K | ﹤0.01% |
+50,000
| New | +$379K |
|
|
RDUS
3528
PUT
DELISTED
Radius Health, Inc.
RDUS
| $442K | ﹤0.01% |
+50,000
| New | +$379K |
|
|
WHWK
3529
Whitehawk Therapeutics
WHWK
$190M
| $441K | ﹤0.01% |
25,989
-10,177
| -28% | -$195K |
|
3530
iShares MSCI Europe Financials ETF
EUFN
$4.14B
| $440K | ﹤0.01% |
23,280
-4,252
| -15% | -$84.3K |
|
|
BXMX
3531
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
| $438K | ﹤0.01% |
30,720
-3,861
| -11% | -$54.1K |
|
3532
Toast
TOST
$18.7B
| $438K | ﹤0.01% |
+20,165
| New | +$455K |
|
|
RCM
3533
DELISTED
R1 RCM Inc. Common Stock
RCM
| $437K | ﹤0.01% |
16,364
-124,729
| -88% | -$3.06M |
|
3534
Marcus Corp
MCS
$894M
| $436K | ﹤0.01% |
24,652
+7,086
| +40% | +$124K |
|
3535
Agilon Health
AGL
$1.53B
| $433K | ﹤0.01% |
683
+264
| +63% | +$136K |
|
3536
Hillman Solutions
HLMN
$1.54B
| $433K | ﹤0.01% |
36,422
+34,693
| +2,007% | +$341K |
|
3537
Stoke Therapeutics
STOK
$1.8B
| $433K | ﹤0.01% |
20,560
-34,234
| -62% | -$686K |
|
3538
4D Molecular Therapeutics
FDMT
$532M
| $432K | ﹤0.01% |
28,595
-54,577
| -66% | -$857K |
|
3539
Pennant Group
PNTG
$1.4B
| $432K | ﹤0.01% |
23,206
+2,465
| +12% | +$41.2K |
|
3540
WisdomTree International AI Enhanced Value Fund
AIVI
$61.7M
| $430K | ﹤0.01% |
10,711
+5,356
| +100% | +$221K |
|
|
BRFS
3541
DELISTED
BRF SA
BRFS
| $429K | ﹤0.01% |
108,025
+50,844
| +89% | +$188K |
|
|
STON
3542
DELISTED
StoneMor Inc.
STON
| $429K | ﹤0.01% |
164,479
-6,810
| -4% | -$17.5K |
|
3543
Keros Therapeutics
KROS
$199M
| $428K | ﹤0.01% |
7,872
-24,248
| -75% | -$1.24M |
|
3544
Ducommun
DCO
$2.7B
| $427K | ﹤0.01% |
8,154
-1,853
| -19% | -$88.3K |
|
3545
ALX Oncology
ALXO
$261M
| $426K | ﹤0.01% |
25,183
-61,494
| -71% | -$1.05M |
|
3546
Banco Santander Chile
BSAC
$16.3B
| $423K | ﹤0.01% |
+18,697
| New | +$374K |
|
3547
Helen of Troy
HELE
$644M
| $423K | ﹤0.01% |
2,156
-5,408
| -71% | -$1.14M |
|
|
FSR
3548
DELISTED
Fisker Inc.
FSR
| $423K | ﹤0.01% |
32,754
-29,809
| -48% | -$373K |
|
3549
Acushnet Holdings
GOLF
$5.93B
| $422K | ﹤0.01% |
10,456
-7,012
| -40% | -$317K |
|
3550
Invesco S&P International Developed Low Volatility ETF
IDLV
$345M
| $422K | ﹤0.01% |
13,555
-9,383
| -41% | -$292K |
|
Similar funds
Citigroup's Q1 2022 Portfolio in Review
As of Q1 2022, Citigroup held 6,926 positions worth $165B, down 12% from $187B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citigroup withdrew a net $11.2B in Q1 2022, closing 497 positions and reducing 3,025 holdings. Its most notable exit was Xilinx Inc, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in ProShares UltraPro Short QQQ worth $126M.
- Citigroup's largest Q1 2022 buy was ProShares UltraPro Short QQQ: 149,740 shares worth $126M.
- Citigroup added most to iShares Russell 2000 ETF in Q1 2022, an estimated $654M increase.
- Citigroup's biggest Q1 2022 reduction was Apple, cutting an estimated $852M.
- Citigroup fully exited Xilinx Inc in Q1 2022, selling an estimated $235M.
- Citigroup's ten largest holdings make up 28% of its $165B portfolio in Q1 2022.
- Citigroup opened 1,006 new positions and closed 497 in Q1 2022.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $165B.
Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.